Kazakhstan's Alzheimer's Cases Surge Fivefold in Just Four Years

Kazakhstan has recorded a sharp rise in Alzheimer's disease cases over the past four years. Official figures show registered diagnoses jumping from 496 in 2021 to 3,706 in 2025. This surge reflects both a growing incidence of the condition and better detection methods. Alzheimer's is a progressive neurological disorder that gradually destroys memory and cognitive function. It accounts for 60-70% of all dementia cases worldwide. Early symptoms often include forgetfulness, confusion with time or place, difficulty handling money, and repeated questioning.

Globally, dementia affects over 55 million people, with nearly 10 million new cases reported each year. The World Health Organization estimates that by 2030, this number will rise to 78 million, reaching 139 million by 2050. The economic burden is also substantial, with dementia costing the global economy $1.3 trillion in 2019 alone. In Kazakhstan, the steep increase in registered cases suggests improved awareness and reporting. However, the disease remains irreversible, making early diagnosis and support crucial for patients and families.

The rising numbers in Kazakhstan mirror a worldwide trend in dementia cases. As populations age, the demand for medical research and care services continues to grow. Alzheimer's remains the seventh leading cause of death globally, highlighting the need for ongoing prevention and treatment efforts.